Mechanism of Somatic Hypermutation in B cell immunity and lymphomagenesis
APA
(2024). Mechanism of Somatic Hypermutation in B cell immunity and lymphomagenesis. SciVideos. https://youtube.com/live/erGODsLQJQ0
MLA
Mechanism of Somatic Hypermutation in B cell immunity and lymphomagenesis. SciVideos, Sep. 16, 2024, https://youtube.com/live/erGODsLQJQ0
BibTex
@misc{ scivideos_ICTS:29631, doi = {}, url = {https://youtube.com/live/erGODsLQJQ0}, author = {}, keywords = {}, language = {en}, title = {Mechanism of Somatic Hypermutation in B cell immunity and lymphomagenesis}, publisher = {}, year = {2024}, month = {sep}, note = {ICTS:29631 see, \url{https://scivideos.org/icts-tifr/29631}} }
Abstract
B cells undergoing physiologically programmed or aberrant genomic alterations provide an opportune system to study the causes and consequences of genome mutagenesis. Activated B cells in germinal centers express activation-induced cytidine deaminase (AID) to accomplish physiological somatic hypermutation (SHM) of their antibody-encoding genes. In attempting to diversify their immunoglobulin (Ig) heavy- and light-chain genes, several B-cell clones successfully optimize their antigen-binding affinities. However, SHM can sometimes occur at non-Ig loci, causing genetic alternations that lay the foundation for lymphomagenesis, particularly diffuse large B-cell lymphoma. Thus, SHM acts as a double-edged sword, bestowing superb humoral immunity at the potential risk of initiating disease. We refer to off-target, non-Ig AID mutations - that are often but not always associated with disease - as aberrant SHM (aSHM). A key challenge in understanding SHM and aSHM is determining how AID targets and...